Amoebiasis historical perspective

Jump to: navigation, search

Amoebiasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Amoebiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Imaging

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Amoebiasis historical perspective On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Amoebiasis historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Amoebiasis historical perspective

CDC onAmoebiasis historical perspective

Amoebiasis historical perspective in the news

Blogs on Amoebiasis historical perspective

to Hospitals Treating Amoebiasis

Risk calculators and risk factors for Amoebiasis historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Serge Korjian M.D.

Overview

Amebiasis is thought to have been discovered by Hippocrates, who described a patient with fever and dysentery. In 1828, the association between dysentery and amebic liver abscess was reported by James Annesley, an Irish physician. In 1875, E. histolytica was first isolated from a patient with dysentery by Fedor Losch, a Russian physician.

Historical Perspective

  • Amebiasis is thought to have been discovered by Hippocrates, who described a patient with fever and dysentery.[1]
  • 1828 - The association between dysentery and amebic liver abscess was reported by James Annesley, an Irish physician.[2]
  • 1875 - E. histolytica was first isolated from a patient with dysentery by Fedor Losch, a Russian physician.[2][3]
  • 1903 - The organism was named Entamoeba histolytica by Fritz Schaudinn, a German zoologist.
  • 1912 - Leonard Rogers, an English pathologist and tropical medicine specialist, described the efficacy of emetine (first treatment) for the treatment of amebiasis.[4]
  • 1925 - The life cycle of E. histolytica was first described by Clifford Dobell, an English protozoologist.[5]

References

  1. Tanyuksel M, Petri WA (2003). "Laboratory diagnosis of amebiasis". Clin Microbiol Rev. 16 (4): 713–29. PMC 207118. PMID 14557296.
  2. 2.0 2.1 Ravdin, J. I. (1988). A history of amebiasis - Amebiasis: human infection by Entamoeba histolytica. New York, N.Y.: John Wiley & Sons, Inc. p. 1-10.
  3. STILWELL GG (1955). "Amebiasis: its early history". Gastroenterology. 28 (4): 606–22. PMID 14366122.
  4. Rogers L (1912). "THE RAPID CURE OF AMOEBIC DYSENTERY AND HEPATITIS BY HYPODERMIC INJECTIONS OF SOLUBLE SALTS OF EMETINE". Br Med J. 1 (2686): 1424–5. PMC 2345206. PMID 20766221.
  5. Brumpt, E (1925). "Étude sommaire de l' "Entamoeba dispar" n. sp. Amibe à kystes quadrinuclées, parasite de l'homme". Bull. Acad. Med. (Paris). 94: 943–952. |access-date= requires |url= (help)



Linked-in.jpg